Wednesday 11 December 2024
Select a region
News

Jersey grandad cancer-free after revolutionary treatment

Jersey grandad cancer-free after revolutionary treatment

Thursday 08 February 2024

Jersey grandad cancer-free after revolutionary treatment

Thursday 08 February 2024


A 71-year-old watch repairer and motorbike enthusiast is celebrating being cancer-free after receiving a revolutionary new treatment in Southampton.

Peter Garland has become the first patient to receive chimeric antigen receptor T-cell therapy at University Hospital Southampton.

He underwent the complex form of cellular therapy which involves collecting and using the patients’ own modified immune cells to treat their condition.

Peter, who was diagnosed with lymphoma, originally underwent chemotherapy but after a brief period in remission was told his cancer had returned.

Not all patients are suitable for CAR T-cell therapy, which comes with risks and will not cure all recipients – but it is capable of helping those with advanced cancers where other available treatments have failed.

It is the newest treatment being delivered by the Blood and Marrow Transplant and Cellular Therapy programme team at UHS, with 21 patients having received the treatment in its first year.

"I had reached the point where chemotherapy just wasn’t cutting it"

Peter said: "I had reached the point where chemotherapy just wasn’t cutting it and my cancer had returned. There wasn’t another option.

"I was told that if I was suitable, having this treatment would give me the best chance of ensuring the lymphoma didn’t return."

Peter_when_lymphoma_returned_for_a_second_time.jpg

Pictured: Peter Garland originally underwent chemotherapy but, after a brief period in remission, was told his cancer had returned.

He continued: “I feel incredibly lucky to have been offered this treatment and to have come through it so well.

"It has already given me another year and I have been able to get back on with my life and that’s amazing.

“It’s now up to me to ensure I take good care of myself, out of respect for all that has been done for me if nothing else.”

"Sharing the experience is the least I can do in return"

The grandfather-of-two still works as a watch repairer, but a lot of his time is spent with family and friends.

He also has a passion for motorcycling, having been riding since the age of 16.

Peter said: “When I was ill everything had to stop. I couldn’t get out on the bikes at all.

"But having that interest and my family and friends of course, was all the incentive I needed to get well again.

“I feel sharing the experience is the least I can do in return, to try and give other people who are starting out on a similar journey some confidence.”

Over 1,300 people have received CAR T-cell therapy treatment via the NHS in England since its introduction, with the provision at UHS among six new centres onboarded in the country over the last year.

"There will be more people who may be helped by this"

Sara Main, UHS Lead Nurse for Bone Marrow Transplant and Cell Therapy, said: “Adding CAR T-cell therapy to the repertoire of treatments we can offer patients at UHS is the culmination of a huge amount of hard work and dedication."

She explained: “It takes ongoing vision and commitment of the doctors, nurses, and allied health professionals together with our quality team to deliver these treatments safely and effectively. It also requires collaboration with many other departments within – and other organisations outside – the hospital.

“We want to not only be able to give all the treatments that are available to patients that may benefit them but to think ahead to our patients and families of the future, as there will be more people who may be helped by this and other types of cellular therapy.”

Sign up to newsletter

 

Comments

Comments on this story express the views of the commentator only, not Bailiwick Publishing. We are unable to guarantee the accuracy of any of those comments.

You have landed on the Bailiwick Express website, however it appears you are based in . Would you like to stay on the site, or visit the site?